The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $93.40

Today's change+0.61 +0.66%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $93.40

Today's change+0.61 +0.66%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp up (U.S.)$0.61

CVS Health Corp closed up Wednesday by (U.S.)$0.61 or 0.66% to (U.S.)$93.40. Over the last five days, shares have lost 3.88% and are down 4.47% for the last year to date. This security has underperformed the S&P 500 by 18.87% during the last year.

Key company metrics

  • Open(U.S.) $92.86
  • Previous close(U.S.) $92.79
  • High(U.S.) $93.53
  • Low(U.S.) $92.31
  • Bid / Ask-- / --
  • YTD % change-4.47%
  • Volume5,226,274
  • Average volume (10-day)4,740,521
  • Average volume (1-month)4,635,011
  • Average volume (3-month)4,948,532
  • 52-week range(U.S.) $86.50 to (U.S.) $106.67
  • Beta0.83
  • Trailing P/E21.50×
  • P/E 1 year forward15.84×
  • Forward PEG1.09×
  • Indicated annual dividend(U.S.) $1.70
  • Dividend yield1.82%
  • Trailing EPS(U.S.) $4.35
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.59%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue43,72543,21541,14638,644
Total other revenue--------
Total revenue43,72543,21541,14638,644
Gross profit7,0156,7447,3016,661
Total cost of revenue36,71036,47133,84531,983
Total operating expense41,91741,03938,41736,313
Selling / general / administrative4,6654,5684,5724,330
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)542--00
Other operating expenses, total--------
Operating income1,8082,1762,7292,331
Interest income (expense), net non-operating-284-288-282-268
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5281,8932,4532,070
Income after tax9241,1471,5001,237
Income tax, total604746953833
Net income9241,1461,4981,246
Total adjustments to net income-4-6----
Net income before extra. items9241,1461,4991,236
Minority interest0-1-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9201,1401,4991,236
Inc. avail. to common incl. extra. items9201,1401,4981,246
Diluted net income9241,1401,4981,246
Dilution adjustment4------
Diluted weighted average shares1,0751,0991,1141,121
Diluted EPS excluding extraordinary itemsvalue per share0.861.041.351.10
Dividends per sharevalue per share0.430.430.350.35
Diluted normalized EPSvalue per share1.161.041.351.10